Skip to main content
Premium Trial:

Request an Annual Quote

GeneGo Licenses Datamining and Pathway Analysis Platform to TGen

NEW YORK, May 16 (GenomeWeb News) - The Translational Genomics Research Institute has licensed GeneGo's datamining and pathway analysis platform, MetaCore, the St. Joseph, Mich.-based company said today.


"GeneGo enables our scientists to generate global pathways and smaller targeted networks," said Edward Suh, chief information officer of TGen, in a company statement.


Last week, GeneGo licensed its MetaCore platform to Exelixis and Procter & Gamble Pharmaceuticals.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.